Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 244

1.

The long non-coding RNA GHSROS facilitates breast cancer cell migration and orthotopic xenograft tumour growth.

Thomas PB, Seim I, Jeffery PL, Gahete MD, Maugham M, Crisp GJ, Stacey A, Shah ET, Walpole C, Whiteside EJ, Nelson CC, Herington AC, Luque RM, Veedu RN, Chopin LK.

Int J Oncol. 2019 Dec;55(6):1223-1236. doi: 10.3892/ijo.2019.4891. Epub 2019 Oct 4.

2.

Insulin Enhances Migration and Invasion in Prostate Cancer Cells by Up-Regulation of FOXC2.

Sarkar PL, Lee W, Williams ED, Lubik AA, Stylianou N, Shokoohmand A, Lehman ML, Hollier BG, Gunter JH, Nelson CC.

Front Endocrinol (Lausanne). 2019 Jul 17;10:481. doi: 10.3389/fendo.2019.00481. eCollection 2019.

3.

Characteristics of Industry Payments to Ophthalmologists in the Open Payments Database.

Slentz DH, Nelson CC, Lichter PR.

JAMA Ophthalmol. 2019 Jul 3. doi: 10.1001/jamaophthalmol.2019.2456. [Epub ahead of print]

PMID:
31268495
4.

Engineering osteoblastic metastases to delineate the adaptive response of androgen-deprived prostate cancer in the bone metastatic microenvironment.

Bock N, Shokoohmand A, Kryza T, Röhl J, Meijer J, Tran PA, Nelson CC, Clements JA, Hutmacher DW.

Bone Res. 2019 Apr 25;7:13. doi: 10.1038/s41413-019-0049-8. eCollection 2019.

5.

Lipid Uptake Is an Androgen-Enhanced Lipid Supply Pathway Associated with Prostate Cancer Disease Progression and Bone Metastasis.

Tousignant KD, Rockstroh A, Taherian Fard A, Lehman ML, Wang C, McPherson SJ, Philp LK, Bartonicek N, Dinger ME, Nelson CC, Sadowski MC.

Mol Cancer Res. 2019 May;17(5):1166-1179. doi: 10.1158/1541-7786.MCR-18-1147. Epub 2019 Feb 26.

PMID:
30808729
6.

Nutrition provider confidence in the Massachusetts Childhood Obesity Research Demonstration (MA-CORD) study.

Cheng ER, Nelson CC, Leung-Strle P, Colchamiro R, Taveras EM, Woo Baidal JA.

Prev Med Rep. 2019 Jan 25;13:289-292. doi: 10.1016/j.pmedr.2019.01.010. eCollection 2019 Mar.

7.

Correction: A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome.

Stylianou N, Lehman ML, Wang C, Fard AT, Rockstroh A, Fazli L, Jovanovic L, Ward M, Sadowski MC, Kashyap AS, Buttyan R, Gleave ME, Westbrook TF, Williams ED, Gunter JH, Nelson CC, Hollier BG.

Oncogene. 2019 Mar;38(13):2436. doi: 10.1038/s41388-018-0587-3.

PMID:
30510231
8.

No effect of unacylated ghrelin administration on subcutaneous PC3 xenograft growth or metabolic parameters in a Rag1-/- mouse model of metabolic dysfunction.

Maugham ML, Seim I, Thomas PB, Crisp GJ, Shah ET, Herington AC, Brown KA, Gregory LS, Nelson CC, Jeffery PL, Chopin LK.

PLoS One. 2018 Nov 20;13(11):e0198495. doi: 10.1371/journal.pone.0198495. eCollection 2018.

9.

Periocular Reconstruction.

Segal KL, Nelson CC.

Facial Plast Surg Clin North Am. 2019 Feb;27(1):105-118. doi: 10.1016/j.fsc.2018.08.011. Review.

PMID:
30420064
10.

Novel Use of Cryopreserved Ultra-thick Human Amniotic Membrane for Management of Anophthalmic Socket Contracture.

Slentz DH, Nelson CC.

Ophthalmic Plast Reconstr Surg. 2019 Mar/Apr;35(2):193-196. doi: 10.1097/IOP.0000000000001264.

PMID:
30407993
11.

Limited short-term effects on human prostate cancer xenograft growth and epidermal growth factor receptor gene expression by the ghrelin receptor antagonist [D-Lys3]-GHRP-6.

Maugham ML, Seim I, Thomas PB, Crisp GJ, Shah ET, Herington AC, Gregory LS, Nelson CC, Jeffery PL, Chopin LK.

Endocrine. 2019 May;64(2):393-405. doi: 10.1007/s12020-018-1796-9. Epub 2018 Nov 2.

PMID:
30390209
12.

A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome.

Stylianou N, Lehman ML, Wang C, Fard AT, Rockstroh A, Fazli L, Jovanovic L, Ward M, Sadowski MC, Kashyap AS, Buttyan R, Gleave ME, Westbrook TF, Williams ED, Gunter JH, Nelson CC, Hollier BG.

Oncogene. 2019 Feb;38(7):913-934. doi: 10.1038/s41388-018-0488-5. Epub 2018 Sep 7. Erratum in: Oncogene. 2018 Dec 3;:.

13.

Transcriptomic analysis of mRNA expression and alternative splicing during mouse sex determination.

Zhao L, Wang C, Lehman ML, He M, An J, Svingen T, Spiller CM, Ng ET, Nelson CC, Koopman P.

Mol Cell Endocrinol. 2018 Dec 15;478:84-96. doi: 10.1016/j.mce.2018.07.010. Epub 2018 Jul 24.

PMID:
30053582
14.

Mining human cancer datasets for kallikrein expression in cancer: the 'KLK-CANMAP' Shiny web tool.

Wang C, Moya L, Clements JA, Nelson CC, Batra J.

Biol Chem. 2018 Sep 25;399(9):983-995. doi: 10.1515/hsz-2017-0322.

PMID:
30052511
15.

Racial/Ethnic Differences in the Effectiveness of a Multisector Childhood Obesity Prevention Intervention.

Nelson CC, Colchamiro R, Perkins M, Taveras EM, Leung-Strle P, Kwass J, Woo Baidal JA.

Am J Public Health. 2018 Sep;108(9):1200-1206. doi: 10.2105/AJPH.2018.304511. Epub 2018 Jul 19.

16.

Early Return to Work Has Benefits for Relief of Back Pain and Functional Recovery After Controlling for Multiple Confounds.

Shaw WS, Nelson CC, Woiszwillo MJ, Gaines B, Peters SE.

J Occup Environ Med. 2018 Oct;60(10):901-910. doi: 10.1097/JOM.0000000000001380.

17.

Identification of Gibberellic Acid Derivatives That Deregulate Cholesterol Metabolism in Prostate Cancer Cells.

Egbewande FA, Sadowski MC, Levrier C, Tousignant KD, White JM, Coster MJ, Nelson CC, Davis RA.

J Nat Prod. 2018 Apr 27;81(4):838-845. doi: 10.1021/acs.jnatprod.7b00929. Epub 2018 Feb 23.

PMID:
29474071
18.

Lymphedema-Distichiasis Syndrome in a Male Patient Followed for 16 Years.

Grisolia ABD, Nelson CC.

Ophthalmic Plast Reconstr Surg. 2018 Mar/Apr;34(2):e63-e65. doi: 10.1097/IOP.0000000000001037.

PMID:
29342028
19.

A microsatellite repeat in PCA3 long non-coding RNA is associated with prostate cancer risk and aggressiveness.

Lai J, Moya L, An J, Hoffman A, Srinivasan S, Panchadsaram J, Walpole C, Perry-Keene JL, Chambers S; Australian Prostate Cancer BioResource, Lehman ML, Nelson CC, Clements JA, Batra J.

Sci Rep. 2017 Dec 4;7(1):16862. doi: 10.1038/s41598-017-16700-y.

20.

Extracellular Vesicles in the Adaptive Process of Prostate Cancer during Inhibition of Androgen Receptor Signaling by Enzalutamide.

Soekmadji C, Rockstroh A, Ramm GA, Nelson CC, Russell PJ.

Proteomics. 2017 Dec;17(23-24). doi: 10.1002/pmic.201600427.

PMID:
29105980
21.

Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumours.

Evans JC, Malhotra M, Sweeney K, Darcy R, Nelson CC, Hollier BG, O'Driscoll CM.

Int J Pharm. 2017 Oct 30;532(1):511-518. doi: 10.1016/j.ijpharm.2017.09.013. Epub 2017 Sep 13.

PMID:
28916296
22.

Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer.

Soekmadji C, Riches JD, Russell PJ, Ruelcke JE, McPherson S, Wang C, Hovens CM, Corcoran NM; Australian Prostate Cancer Collaboration BioResource, Hill MM, Nelson CC.

Oncotarget. 2016 Aug 8;8(32):52237-52255. doi: 10.18632/oncotarget.11111. eCollection 2017 Aug 8.

23.

Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancer.

Soekmadji C, Corcoran NM, Oleinikova I, Jovanovic L; Australian Prostate Cancer Collaboration BioResource, Ramm GA, Nelson CC, Jenster G, Russell PJ.

Prostate. 2017 Oct;77(14):1416-1423. doi: 10.1002/pros.23403. Epub 2017 Aug 29. Review.

PMID:
28856701
24.

Discovery of thalicthuberine as a novel antimitotic agent from nature that disrupts microtubule dynamics and induces apoptosis in prostate cancer cells.

Levrier C, Rockstroh A, Gabrielli B, Kavallaris M, Lehman M, Davis RA, Sadowski MC, Nelson CC.

Cell Cycle. 2018;17(5):652-668. doi: 10.1080/15384101.2017.1356512.

25.

Clinical effectiveness of the massachusetts childhood obesity research demonstration initiative among low-income children.

Taveras EM, Perkins M, Anand S, Woo Baidal JA, Nelson CC, Kamdar N, Kwass JA, Gortmaker SL, Barrett JL, Davison KK, Land T.

Obesity (Silver Spring). 2017 Jul;25(7):1159-1166. doi: 10.1002/oby.21866.

26.

Childhood obesity prevention in the women, infants, and children program: Outcomes of the MA-CORD study.

Woo Baidal JA, Nelson CC, Perkins M, Colchamiro R, Leung-Strle P, Kwass JA, Gortmaker SL, Davison KK, Taveras EM.

Obesity (Silver Spring). 2017 Jul;25(7):1167-1174. doi: 10.1002/oby.21865.

27.

Neonatal Graves' Eye Disease.

Segal KL, Nelson CC.

Ophthalmology. 2017 May;124(5):673. doi: 10.1016/j.ophtha.2016.11.009. No abstract available.

PMID:
28433126
28.

Whole-Genome Sequence of the Metastatic PC3 and LNCaP Human Prostate Cancer Cell Lines.

Seim I, Jeffery PL, Thomas PB, Nelson CC, Chopin LK.

G3 (Bethesda). 2017 Jun 7;7(6):1731-1741. doi: 10.1534/g3.117.039909.

29.

Tangent screen perimetry in the evaluation of visual field defects associated with ptosis and dermatochalasis.

Fuller ML, Briceño CA, Nelson CC, Bradley EA.

PLoS One. 2017 Mar 29;12(3):e0174607. doi: 10.1371/journal.pone.0174607. eCollection 2017.

30.

Insights from engraftable immunodeficient mouse models of hyperinsulinaemia.

Maugham ML, Thomas PB, Crisp GJ, Philp LK, Shah ET, Herington AC, Chen C, Gregory LS, Nelson CC, Seim I, Jeffery PL, Chopin LK.

Sci Rep. 2017 Mar 28;7(1):491. doi: 10.1038/s41598-017-00443-x.

31.

Evaluation of Patients with Facial Palsy and Ophthalmic Sequelae: A 23-Year Retrospective Review.

Joseph SS, Joseph AW, Smith JI, Niziol LM, Musch DC, Nelson CC.

Ophthalmic Epidemiol. 2017 Oct;24(5):341-345. doi: 10.1080/09286586.2017.1294186. Epub 2017 Mar 20.

PMID:
28319442
32.

Key Organizational Characteristics for Integrated Approaches to Protect and Promote Worker Health in Smaller Enterprises.

McLellan DL, Williams JA, Katz JN, Pronk NP, Wagner GR, Cabán-Martinez AJ, Nelson CC, Sorensen G.

J Occup Environ Med. 2017 Mar;59(3):289-294. doi: 10.1097/JOM.0000000000000949.

PMID:
28267100
33.

Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality.

Tse BWC, Volpert M, Ratther E, Stylianou N, Nouri M, McGowan K, Lehman ML, McPherson SJ, Roshan-Moniri M, Butler MS, Caradec J, Gregory-Evans CY, McGovern J, Das R, Takhar M, Erho N, Alshalafa M, Davicioni E, Schaeffer EM, Jenkins RB, Ross AE, Karnes RJ, Den RB, Fazli L, Gregory PA, Gleave ME, Williams ED, Rennie PS, Buttyan R, Gunter JH, Selth LA, Russell PJ, Nelson CC, Hollier BG.

Oncogene. 2017 Jun 15;36(24):3417-3427. doi: 10.1038/onc.2016.482. Epub 2017 Jan 16.

34.

Prevalence of Body Dysmorphic Disorder and Surgeon Diagnostic Accuracy in Facial Plastic and Oculoplastic Surgery Clinics.

Joseph AW, Ishii L, Joseph SS, Smith JI, Su P, Bater K, Byrne P, Boahene K, Papel I, Kontis T, Douglas R, Nelson CC, Ishii M.

JAMA Facial Plast Surg. 2017 Jul 1;19(4):269-274. doi: 10.1001/jamafacial.2016.1535.

35.

6α-Acetoxyanopterine: A Novel Structure Class of Mitotic Inhibitor Disrupting Microtubule Dynamics in Prostate Cancer Cells.

Levrier C, Sadowski MC, Rockstroh A, Gabrielli B, Kavallaris M, Lehman M, Davis RA, Nelson CC.

Mol Cancer Ther. 2017 Jan;16(1):3-15. doi: 10.1158/1535-7163.MCT-16-0325. Epub 2016 Oct 19.

36.

FOXP3+ Tregs require WASP to restrain Th2-mediated food allergy.

Lexmond WS, Goettel JA, Lyons JJ, Jacobse J, Deken MM, Lawrence MG, DiMaggio TH, Kotlarz D, Garabedian E, Sackstein P, Nelson CC, Jones N, Stone KD, Candotti F, Rings EH, Thrasher AJ, Milner JD, Snapper SB, Fiebiger E.

J Clin Invest. 2016 Oct 3;126(10):4030-4044. doi: 10.1172/JCI85129. Epub 2016 Sep 19.

37.

Assessment of the Abbreviated National Eye Institute Visual Function Questionnaire (NEI VFQ 9) in blepharoptosis and dermatochalasis.

Briceño CA, Fuller ML, Bradley EA, Nelson CC.

Arq Bras Oftalmol. 2016 Jul-Aug;79(4):226-8. doi: 10.5935/0004-2749.20160065.

38.

Short term ex-vivo expansion of circulating head and neck tumour cells.

Kulasinghe A, Perry C, Warkiani ME, Blick T, Davies A, O'Byrne K, Thompson EW, Nelson CC, Vela I, Punyadeera C.

Oncotarget. 2016 Sep 13;7(37):60101-60109. doi: 10.18632/oncotarget.11159.

39.

A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer.

Selth LA, Das R, Townley SL, Coutinho I, Hanson AR, Centenera MM, Stylianou N, Sweeney K, Soekmadji C, Jovanovic L, Nelson CC, Zoubeidi A, Butler LM, Goodall GJ, Hollier BG, Gregory PA, Tilley WD.

Oncogene. 2017 Jan 5;36(1):24-34. doi: 10.1038/onc.2016.185. Epub 2016 Jun 6.

PMID:
27270433
40.

Erratum to: Fusion transcript loci share many genomic features with non-fusion loci.

Lai J, An J, Seim I, Walpole C, Hoffman A, Moya L, Srinivasan S, Perry-Keene JL; Australian Prostate Cancer Bioresource, Wang C, Lehman ML, Nelson CC, Clements JA, Batra J.

BMC Genomics. 2016 Jun 3;17(1):424. No abstract available.

41.

Recurrence and Survival in Patients With Merkel Cell Carcinoma Undergoing Surgery Without Adjuvant Radiation Therapy to the Primary Site.

Frohm ML, Griffith KA, Harms KL, Hayman JA, Fullen DR, Nelson CC, Wong SL, Schwartz JL, Bichakjian CK.

JAMA Dermatol. 2016 Sep 1;152(9):1001-7. doi: 10.1001/jamadermatol.2016.1428.

PMID:
27248515
42.

Validation and Dimensionality of the Integration of Health Protection and Health Promotion Score: Evidence From the PULSE Small Business and VA Medical Center Surveys.

Williams JA, Schult TM, Nelson CC, Cabán-Martinez AJ, Katz JN, Wagner GR, Pronk NP, Sorensen G, McLellan DL.

J Occup Environ Med. 2016 May;58(5):499-504. doi: 10.1097/JOM.0000000000000732.

43.

Bioactive Dihydro-β-agarofuran Sesquiterpenoids from the Australian Rainforest Plant Maytenus bilocularis.

Wibowo M, Levrier C, Sadowski MC, Nelson CC, Wang Q, Holst J, Healy PC, Hofmann A, Davis RA.

J Nat Prod. 2016 May 27;79(5):1445-53. doi: 10.1021/acs.jnatprod.6b00190. Epub 2016 Apr 27.

PMID:
27120798
44.

Repositioning "old" drugs for new causes: identifying new inhibitors of prostate cancer cell migration and invasion.

Shah ET, Upadhyaya A, Philp LK, Tang T, Skalamera D, Gunter J, Nelson CC, Williams ED, Hollier BG.

Clin Exp Metastasis. 2016 Apr;33(4):385-99. doi: 10.1007/s10585-016-9785-y. Epub 2016 Mar 1.

PMID:
26932199
45.

Implementing an Integrated Health Protection/Health Promotion Intervention in the Hospital Setting: Lessons Learned From the Be Well, Work Well Study.

Sorensen G, Nagler EM, Hashimoto D, Dennerlein JT, Theron JV, Stoddard AM, Buxton O, Wallace LM, Kenwood C, Nelson CC, Tamers SL, Grant MP, Wagner G.

J Occup Environ Med. 2016 Feb;58(2):185-94. doi: 10.1097/JOM.0000000000000592.

46.

The ascidian natural product eusynstyelamide B is a novel topoisomerase II poison that induces DNA damage and growth arrest in prostate and breast cancer cells.

Liberio MS, Sadowski MC, Davis RA, Rockstroh A, Vasireddy R, Lehman ML, Nelson CC.

Oncotarget. 2015 Dec 22;6(41):43944-63. doi: 10.18632/oncotarget.6267.

47.

Fusion transcript loci share many genomic features with non-fusion loci.

Lai J, An J, Seim I, Walpole C, Hoffman A, Moya L, Srinivasan S, Perry-Keene JL; Australian Prostate Cancer Bioresource, Wang C, Lehman ML, Nelson CC, Clements JA, Batra J.

BMC Genomics. 2015 Dec 1;16:1021. doi: 10.1186/s12864-015-2235-4. Erratum in: BMC Genomics. 2016;17:424.

48.

Cytotoxic C20 Diterpenoid Alkaloids from the Australian Endemic Rainforest Plant Anopterus macleayanus.

Levrier C, Sadowski MC, Nelson CC, Davis RA.

J Nat Prod. 2015 Dec 24;78(12):2908-16. doi: 10.1021/acs.jnatprod.5b00509. Epub 2015 Nov 24.

PMID:
26600001
49.

The Emerging Role of Extracellular Vesicle-Mediated Drug Resistance in Cancers: Implications in Advanced Prostate Cancer.

Soekmadji C, Nelson CC.

Biomed Res Int. 2015;2015:454837. doi: 10.1155/2015/454837. Epub 2015 Oct 26. Review.

50.

Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer.

Tevz G, McGrath S, Demeter R, Magrini V, Jeet V, Rockstroh A, McPherson S, Lai J, Bartonicek N, An J, Batra J, Dinger ME, Lehman ML, Williams ED, Nelson CC.

Mol Cell Endocrinol. 2016 Jan 15;420:159-68. doi: 10.1016/j.mce.2015.10.011. Epub 2015 Oct 21.

Supplemental Content

Loading ...
Support Center